Abstract:Radiation-induced xerostomia remains one of common side effects for radiotherapy (RT) of nasopharyngeal carcinoma (NPC) and severely affects the quality of life for the NPC patients. We aim to investigate the feasibility of predicting parotid glands secretory function based on the changes of apparent diffusion coefficient (ADC) map from diffusion weighted MRI (DWI) of bilateral parotid glands during RT for NPC patients and to analyze the correlations between the delivered radiation dose, volume reduction of parotid glands and the salivary secretary function. Seventy-five NPC patients treated with IMRT were enrolled in the study. DWI data were acquired on a 3.0T MRI system at pre-RT, the 5th and 15th fractions and immediately post-RT. The ADC maps were created in the ipsilateral (IP) and contralateral parotid gland (CP). Chewing stimulating tests were used to evaluate the saliva secretion. Pearson analysis was used to assess the correlation between ADC, delivered dose, volume reduction, and saliva secretion. Mean ADC increases and volume reductions in both parotid glands were observed during RT. These changes generally occurred in two stages. At the 5th fraction, with the average (± standard deviation) delivered doses of 5.11 ± 6.73Gy (IP) and 4.84±4.01Gy (CP), the average saliva secretions reduced from 2.35 ± 0.18g (pre-RT) to 2.25 ± 0.18g (5th fraction). During this first stage, the mean ADC increased significantly by 16.51 ± 14.82% (IP), 13.44 ± 10.87% (CP), while the volumes of parotid glands had minimal changes (IP: 23.42 ± 8.33cm3 vs 23.12 ± 8.11cm3, CP: 24.37 ± 9.13 cm3 vs 23.81 ± 9.07 cm3). The increased mean ADC had a positive correlation with the delivered dose (r1 = 0.57, r2 = 0.58) and negative correlation with the decreased saliva secretion (r1 = -0.57, r2 = -0.65). In the second stage (from the 5th fraction to post-RT), with the total mean delivered doses to the parotid glands of 27.64 ± 3.63 Gy (IP) and 26.13 ± 2.16 Gy (CP), the average saliva secretion decreased to 1.70 ± 0.14 g (15th fraction) and 1.34 ± 0.15 g (post-RT). The mean ADC increased by 40.38 ± 21.91% (IP), 40.06 ± 23.91% (CP) in this stage, while the volumes of parotid glands decreased by 41.20 ± 10.77% (IP), 39.18 ± 11.88% (CP). The radiation dose positively correlated to increased ADC, and negatively correlated to the volume reduction and decreased salivary secretion. During radiotherapy for NPC, the ADC values of parotid glands increase dramatically. The increase positively correlates to radiation dose, and negatively correlates to the volume reduction and salivary secretion decrease. The mean ADC increases at the 5th fraction even no volume change is observed, indicating that the ADC is more sensitive biomarker that may be used to predict xerostomia in an early stage during RT for NPC, leaving enough time to adapt the remaining treatment if necessary.

Scintigraphic Assessment of Parotid Function Prior to and after IMRT for Pantients with Nasopharygeal Carcinoma

[The Relationship Between the Parotid Glands Function and the Dose-Volume Effect in Nasopharyngeal Carcinoma Patients with Intensity-Modulated Radiation Therapy].

Comparison of Quality of Life in Patients with Nasopharyngeal Carcinoma Receiving Conventional External Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy

Investigation by nuclide imaging the effect of radiotherapy on parotid function of patients with nasopharyngeal cancer

Relationship between the parotid glands function and the dose-volume effect in nasopharyngeal carcinoma patients with intensity-modulated radiotherapy by radionuclide imaging

Influence of intensity-modulated radiation therapy on parotid function in nasopharyngeal carcinoma

Function protection of the parotid gland after intensity modulated radiotherapy for thirty-six patients of nasopharyngeal carcinoma

Protective effect of intensity-modulated radiation therapy on salivary gland function in nasopharyngeal carcinoma patients

Volumetric and Geometric Changes of Parotids Occurring During IMRT for Nasopharyngeal Carcinoma(NPC)Using Daily CBCT

Protection of Parotid Function by Intensity Modulated Radiation Therapy

Early Changes of Irradiated Parotid Glands Evaluated by T1rho-Weighted Imaging: A Pilot Study.

The Efficacy of IMRT Combined with Chemotherapy at Various Time Points on Parotid Function in Patients with Nasopharyngeal Carcinoma

Multi‑parameter Quantitative Magnetic Resonance Imaging in the Early Assessment of Radiation‑induced Parotid Damage in Patients with Nasopharyngeal Carcinoma Following Intensity‑modulated Radiotherapy.

Superficial Parotid Lobe-Sparing Delineation Approach: A Better Method Of Dose Optimization To Protect The Parotid Gland In Intensity-Modulated Radiotherapy For Nasopharyngeal Carcinoma

Actual Anatomical and Dosimetric Changes of Parotid Glands in Nasopharyngeal Carcinoma Patients During Intensity Modulated Radiation Therapy

Early evaluation of radiation-induced parotid damage in patients with nasopharyngeal carcinoma by T2 mapping and mDIXON Quant imaging: initial findings

Preliminary Research on Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy

Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Early Prediction of Parotid Glands Secretory Function Based on MRI-ADC Acquired During Radiotherapy for Nasopharyngeal Carcinoma: A Phase II Prospective Study

Early assessment of radiation-induced parotid damage with T2 ? mapping

Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation